These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 20473854

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
    Piersma SJ, Welters MJ, van der Hulst JM, Kloth JN, Kwappenberg KM, Trimbos BJ, Melief CJ, Hellebrekers BW, Fleuren GJ, Kenter GG, Offringa R, van der Burg SH.
    Int J Cancer; 2008 Feb 01; 122(3):486-94. PubMed ID: 17955486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD4(+)CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia.
    Molling JW, de Gruijl TD, Glim J, Moreno M, Rozendaal L, Meijer CJ, van den Eertwegh AJ, Scheper RJ, von Blomberg ME, Bontkes HJ.
    Int J Cancer; 2007 Oct 15; 121(8):1749-55. PubMed ID: 17582606
    [Abstract] [Full Text] [Related]

  • 7. Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.
    de Jong A, van der Hulst JM, Kenter GG, Drijfhout JW, Franken KL, Vermeij P, Offringa R, van der Burg SH, Melief CJ.
    Int J Cancer; 2005 Mar 20; 114(2):274-82. PubMed ID: 15540211
    [Abstract] [Full Text] [Related]

  • 8. Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.
    van Poelgeest MI, Visconti VV, Aghai Z, van Ham VJ, Heusinkveld M, Zandvliet ML, Valentijn AR, Goedemans R, van der Minne CE, Verdegaal EM, Trimbos JB, van der Burg SH, Welters MJ.
    Cancer Immunol Immunother; 2016 Dec 20; 65(12):1451-1463. PubMed ID: 27619514
    [Abstract] [Full Text] [Related]

  • 9. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X, Wang T, Xu M, Xiao L, Luo Y, Huang W, Zhang Y, Geng W.
    Hum Immunol; 2014 Dec 20; 75(12):1203-9. PubMed ID: 25446402
    [Abstract] [Full Text] [Related]

  • 10. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 20; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
    Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG, van der Burg SH, Fleuren GJ.
    Clin Cancer Res; 2008 Apr 01; 14(7):2028-35. PubMed ID: 18381941
    [Abstract] [Full Text] [Related]

  • 14. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.
    Evans EM, Man S, Evans AS, Borysiewicz LK.
    Cancer Res; 1997 Jul 15; 57(14):2943-50. PubMed ID: 9230206
    [Abstract] [Full Text] [Related]

  • 15. Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer.
    Oerke S, Höhn H, Zehbe I, Pilch H, Schicketanz KH, Hitzler WE, Neukirch C, Freitag K, Maeurer MJ.
    Int J Cancer; 2005 May 01; 114(5):766-78. PubMed ID: 15609316
    [Abstract] [Full Text] [Related]

  • 16. The tumor area occupied by Tbet+ cells in deeply invading cervical cancer predicts clinical outcome.
    Gorter A, Prins F, van Diepen M, Punt S, van der Burg SH.
    J Transl Med; 2015 Sep 10; 13():295. PubMed ID: 26357849
    [Abstract] [Full Text] [Related]

  • 17. CD4+ tumor-infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7.
    Höhn H, Pilch H, Günzel S, Neukirch C, Hilmes C, Kaufmann A, Seliger B, Maeurer MJ.
    J Immunol; 1999 Nov 15; 163(10):5715-22. PubMed ID: 10553103
    [Abstract] [Full Text] [Related]

  • 18. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H, Hoehn H, Schmidt M, Steiner E, Tanner B, Seufert R, Maeurer M.
    Zentralbl Gynakol; 2002 Nov 15; 124(8-9):406-12. PubMed ID: 12655469
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
    Nimako M, Fiander AN, Wilkinson GW, Borysiewicz LK, Man S.
    Cancer Res; 1997 Nov 01; 57(21):4855-61. PubMed ID: 9354449
    [Abstract] [Full Text] [Related]

  • 20. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.
    Gut; 2009 Apr 01; 58(4):520-9. PubMed ID: 19022917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.